BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17553070)

  • 1. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
    Lally JA; Gnall EM; Seltzer J; Kowey PR
    J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy for atrial fibrillation.
    Mohammed KS; Kowey PR; Musco S
    Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.
    Davis EM; Packard KA; Hilleman DE
    Pharmacotherapy; 2010 Jul; 30(7):749, 274e-318e. PubMed ID: 20575638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
    Chávez LL
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-antiarrhythmic drugs to prevent atrial fibrillation.
    Moro C; Hernández-Madrid A; Matía R
    Am J Cardiovasc Drugs; 2010; 10(3):165-73. PubMed ID: 20524718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing face of postoperative atrial fibrillation prevention: a review of current medical therapy.
    Mayson SE; Greenspon AJ; Adams S; Decaro MV; Sheth M; Weitz HH; Whellan DJ
    Cardiol Rev; 2007; 15(5):231-41. PubMed ID: 17700382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New evidence of anti-inflammatory interventions in atrial fibrillation.
    Liu T; Li GP
    Eur Heart J; 2006 Feb; 27(4):500; author reply 501. PubMed ID: 16361323
    [No Abstract]   [Full Text] [Related]  

  • 11. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the use of non-antiarrhythmic drugs and postoperative atrial fibrillation.
    Ozaydin M; Turker Y; Peker O; Erdogan D; Varol E; Dogan A; Ibrisim E
    Int J Cardiol; 2010 Oct; 144(2):304-6. PubMed ID: 19282043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and prevention of atrial fibrillation with non-antiarrhythmic pharmacologic therapy.
    Lozano HF; Conde CA; Florin T; Lamas GA
    Heart Rhythm; 2005 Sep; 2(9):1000-7. PubMed ID: 16171759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial fibrillation: rhythm or rate control?].
    Le Heuzey JY; Saïd MA; Paziaud O
    Rev Prat; 2002 Jun; 52(12):1335-8. PubMed ID: 12187898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies.
    Baker WL; White CM
    Ann Pharmacother; 2007 Apr; 41(4):587-98. PubMed ID: 17374620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
    Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y
    J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upstream effect for atrial fibrillation: still a dilemma?
    Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.